Skip to content

The effect of biodegradable bone cement for the augmentation of internally-fixed hip fracture using intramedullary nail in old aged patients

To evaluate the clinical and radiological results of biodegradable calcium phosphate bone cement for the augmentation of internally-fixed unstable trochanteric fracture using intramedullary nail

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003515
Enrollment
20
Registered
2019-02-15
Start date
2015-10-23
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kangdong Sacred Heart Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The trial included patients with unstable trochanteric (three or four parts fractures, AO type A2, Evans unstable Type 1). Additional inclusion criteria were as follows: age more than 65 years, walking with or without support, less than 72 hours between the fracture and surgery, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1) stable two parts factures (AO type A1, Evans stable Type 1); 2) transtrochanteric fractures with a transverse of reversed/oblique fracture line at the level of the lesser trochanter (AO type A3, Evans Type 2) 3) pathological fractures related to tumors and subtrochanteric fractures; 4) tip-apex distance (TAD) > 18 mm 5) limited ability to perform objective functional tests (dementia, serious concomitant illness or mental instability, or neurosensory, neuromuscular or musculoskeletal deficiency 6) soft-tissue infection at the operation site 7) concurrent fractures that would affect the post-operative functional outcome.

Design outcomes

Primary

MeasureTime frame
pain VAS (visual analogue scale);time to hopital ambulation;time to bone union

Secondary

MeasureTime frame
complication

Countries

Korea, Republic of

Contacts

Public ContactByung Lee

Kangdong Sacred Heart Hospital

oselite@naver.com+82-2-2224-2230

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026